LabCorp and its Specialty Testing Group, a fully integrated portfolio of specialty and esoteric testing laboratories.
Most commonly measured in the evaluation of low testosterone (possible androgen deficiency) in men; also commonly used in the evaluation of women with signs and symptoms suggestive of excess male hormones (androgens)
When you have signs and symptoms of increased or decreased testosterone and the total testosterone measurement is inconsistent with your symptoms
A blood sample drawn from a vein in your arm
None; however, testosterone is best measured in the morning because in men, testosterone levels demonstrate diurnal variation with higher levels in the morning.
Sex hormone binding globulin (SHBG) is a protein produced by the liver that transports the hormones testosterone (an androgen), dihydrotestosterone (DHT) (an androgen), and estradiol (an estrogen) in the blood as biologically inactive forms. Changes in SHBG levels can affect the amount of hormone that is available to be used by the body's tissues. This test measures the level of SHBG in the blood and is most often used to help evaluate patients for testosterone deficiency or excess.
In men, about 45% to 65% of testosterone in blood is normally bound to SHBG, with the remainder weakly and reversibly bound to albumin (the main protein in the blood). Only about 2% to 3% of testosterone is immediately available to the tissues as free testosterone, but testosterone that is weakly bound to albumin is also bioavailable and can be readily taken up by the body's tissues.
Slightly more testosterone is bound to SHBG in the blood (66% to 78%) in women than in men. In women, SHBG plays an integral role in regulating the levels of bioavailable male sex hormones (androgens) and estrogens circulating throughout the body. SHBG has a higher affinity for the androgens testosterone and DHT and so in the setting of low SHBG, women may have signs and symptoms related to androgen excess.
A total testosterone test does not distinguish between bound and unbound testosterone but determines the overall level of testosterone in the plasma. In many cases, this test is sufficient to evaluate patients for excess or deficient testosterone production. However, if your SHBG level is not normal, then the total testosterone may not be an accurate representation of the amount of testosterone that is available to your tissues. An SHBG test may be performed when your signs and symptoms do not correlate with the results of a total testosterone test.
The sex hormone binding globulin (SHBG) test may be used to help evaluate men for low testosterone and women for excess testosterone production. It may be ordered in conjunction with other tests to evaluate the status of a person's sex hormones.
SHBG in men
SHBG and total testosterone levels may be ordered for an adult male to help determine the cause of infertility, a decreased sex drive, or erectile dysfunction. Measurement of SHBG in addition to testosterone is especially helpful when total testosterone results are inconsistent with clinical signs.
Measurement of total testosterone in the blood does not distinguish between bound and unbound (bioavailable) testosterone but, as the name implies, determines the overall quantity of testosterone in the blood. In many cases, this is sufficient to evaluate patients for the possibility of excess or deficient testosterone production. However, if a person's SHBG level is not normal, then the total testosterone may not be an accurate representation of the amount of testosterone that is available to the body's tissues.
Increased SHBG in men may be associated with symptoms of low testosterone levels (hypogonadism) because less testosterone is available to the body's tissues. Low testosterone leads to increased production of SHBG, further decreasing the amount of testosterone available to tissues.
The Endocrine Society professional guidelines recommend measuring total testosterone in the initial screen for testosterone deficiency in men. If abnormal, the test is repeated on another day. If repeat results are low-normal and/or if SHBG is abnormal, one of the following is recommended:
SHBG in women
In women, small amounts of testosterone are produced by the ovaries and the adrenal glands. Even slight increases in testosterone production can disrupt the balance of hormones and cause symptoms such as irregular or missed menstrual periods, infertility, acne, and excess facial and body hair (hirsutism). These signs and symptoms and others are often seen with polycystic ovary syndrome (PCOS), a condition characterized by an excess production of male sex hormones (androgens). SHBG and testosterone testing may be useful in helping to detect and evaluate excess testosterone production and/or decreased SHBG concentrations and in evaluating women suspected of having PCOS.
Currently, the SHBG test is not performed frequently or routinely. SHBG is ordered primarily when the total testosterone results do not seem to be consistent with clinical signs and symptoms, such as infertility, decreased sex drive, and erectile dysfunction in men or infertility, irregular menstrual periods, and excess facial and body hair in women.
A high SHBG level means that it is likely that less free testosterone is available to your tissues than is indicated by the total testosterone test. A low SHBG level means that more of the total testosterone is bioavailable and not bound to SHBG. This information may be important in your overall evaluation when you have signs and symptoms of a condition related to excess or deficient sex hormone production.
Increased SHBG levels may be seen in:
Decreases in SHBG are seen with:
SHBG concentrations are normally high in children of both sexes. After puberty, SHBG levels decrease more rapidly in males than in females. Levels are normally stable in adults and then begin to increase in the elderly male at the same time that total testosterone levels begin to decrease. In postmenopausal women, SHBG, testosterone, and estrogen concentrations decrease as hormone production by the ovaries tapers off.
Not yet, but researchers are evaluating conditions in which there are changes in SHBG levels to see if there may be additional clinical uses for the test. Recent studies have identified that there may be a link between SHBG levels and insulin resistance in type 2 diabetes.
Having measured the total testosterone and SHBG levels, your healthcare practitioner or the laboratory can calculate the free testosterone level, which is one of the best measures of the active testosterone level in the plasma.
Testing for the albumin level and one or more other sex hormones, such as prolactin, estradiol, LH (luteinizing hormone) and FSH (follicle stimulating hormone), may also be performed to evaluate your existing balance of hormones.
Sources Used for Current Review
Qingtao Y, et al. Association of total testosterone, free testosterone, bioavailable testosterone, sex hormone–binding globulin, and hypertension. Medicine (Baltimore). 2019 May; 98(20): e15628. Published online 2019 May 17. doi: 10.1097/MD.0000000000015628 Accessed July 2019.
(©2019) Mayo Medical Laboratories. SHBG: Sex Hormone-Binding Globulin (SHBG), Serum: Clinical and Interpretive. Available online at https://www.mayomedicallaboratories.com/test-catalog/Clinical+and+Interpretive/9285. Accessed July 2019.
(July 2017) ARUP Consult. Male Hypogonadism. Available online at https://arupconsult.com/content/hypogonadism-male. Accessed July 2019.
Sources Used for Previous Reviews
Thomas, Clayton L., Editor (1997). Taber's Cyclopedic Medical Dictionary. F.A. Davis Company, Philadelphia, PA [18th Edition].
Pagana, Kathleen D. & Pagana, Timothy J. (2001). Mosby's Diagnostic and Laboratory Test Reference 5th Edition: Mosby, Inc., Saint Louis, MO.
(© 2004). Sex Hormone Binding Globulin. ARUP's Guide to Clinical Laboratory Testing [On-line information]. Available online at http://www.arup-lab.com/guides/clt/tests/clt_193b.jsp#1147406.
(© 2004). Testosterone, Bioavailable and Sex Hormone Binding Globulin. ARUP's Guide to Clinical Laboratory Testing [On-line information]. Available online at http://www.arup-lab.com/guides/clt/tests/clt_225b.jsp#1148913.
Camillo, P. (2004 January 27). How Should I Handle Complaints of Decreased Libido in Female Patients? Medscape, Ask the Experts about Women's Health for Advanced Practice Nurses [On-line information]. Available online at http://www.medscape.com/viewarticle/466490?src=search.
Dennerstein, L. (2003 February 12). Depressed Libido in the Postmenopausal Woman. Medscape, Ask the Experts about Menopause [On-line information]. Available online at http://www.medscape.com/viewarticle/448554.
Reuters Health (2004 February 4). Postmenopausal Endogenous Hormones Influence Endometrial Cancer Risk. National Cancer Institute [On-line News]. Available online at http://ctep.info.nih.gov/resources/gcig/news020404.html.
Tenover, J. (2001). Male Hormone Replacement Therapy Including "Andropause." WellMax.org [On-line News, Essays & Articles]. Available online at http://www.wellmax.org/NewsPub/Stories/2001/05/07/9892607709.html.
Patient's Guide to Low Testosterone, 2003 Edition. Medem Medical Library [On-line information by The Hormone Foundation and Endocrine Society]. Available online at http://www.medem.com/medlb/article_detaillb.cfm?article_ID=ZZZO7PDVDLC&sub_cat=57.
Snyder, P. (2003 September 9). Testes and Testicular Disorders. Medscape, from WebMD Scientific American® Medicine 2003, What's New in Medicine [On-line information]. Available online at http://www.medscape.com/viewarticle/461007.
Allan, C. and McLachlan, R. (2004 June 3). Age-Related Changes in Testosterone and the Role of Replacement Therapy in Older Men. Medscape, from Clin Endocrinol 60(6): 653-670, 2004 [On-line journal article]. Available online at http://www.medscape.com/viewarticle/479523?src=search.
Matsumoto, A. (2008 June 27). Diagnosis and Evaluation of Male Hypogonadism CME. Medscape Today, Selection from: Men's Sexual Health Consult Collection: Testosterone Replacement Therapy in the VA Setting [On-line information]. Available online at http://www.medscape.com/viewarticle/575491. Accessed on 7-30-08.
Chang, R. (2007 September 14). The Reproductive Phenotype in Polycystic Ovary Syndrome CME. Medscape From Nature Clinical Practice Endocrinology & Metabolism [On-line information]. Available online at http://www.medscape.com/viewarticle/562712. Accessed on 7-30-08.
Sabatini, L. (2007 May 29, Updated). Androgen Excess. emedicine [On-line information]. Available online at http://www.emedicine.com/med/TOPIC3489.HTM. Accessed on 7-30-08.
Anawalt, B. (2007 June Reviewed). Male Reproductive Endocrinology, Introduction. Merck Manual for Healthcare Professionals [On-line information]. Available online at http://www.merck.com/mmpe/sec17/ch227/ch227a.html?qt=SHBG&alt=sh. Accessed on 7-30-08.
Anawalt, B. (Revised 2010 January). Male Reproductive Endocrinology. The Merck Manual for Healthcare Professionals [On-line information]. Available online through http://www.merckmanuals.com. Accessed January 2012.
Dandona, P and Rosenberg, M. (2010 May 10). A Practical Guide to Male Hypogonadism in The Primary Care Setting: Clinical Presentation and Diagnosis. Medscape Today News from Int J Clin Pract. 2010;64(6):682-696 [On-line information]. Available online at http://www.medscape.com/viewarticle/721069_4. Accessed January 2012.
Peter, A. et. al. (2010 December 16). Relationships of Circulating Sex Hormone–Binding Globulin with Metabolic Traits in Humans. Medscape Today News from Diabetes. 2010;59 (12) [On-line information]. Available online at http://www.medscape.com/viewarticle/733605. Accessed January 2012.
(Updated © 1995-2012). Test ID: SHBG9285 Sex Hormone-Binding Globulin (SHBG), Serum Mayo Clinic Mayo Medical Laboratories [On-line information]. Available online at http://www.mayomedicallaboratories.com/test-catalog/Overview/9285. Accessed January 2012.
(Updated 2011 July). Hypogonadism, Male. ARUP Consult [On-line information]. Available online at http://www.arupconsult.com/Topics/HypogonadismMale.html?client_ID=LTD#tabs=0. Accessed January 2012.
Lucidi, R. et. al. (Updated 2011 October 25). Polycystic Ovarian Syndrome. Medscape Reference [On-line information]. Available online at http://emedicine.medscape.com/article/256806-overview. Accessed January 2012.
Pagana, K. D. & Pagana, T. J. (© 2011). Mosby’s Diagnostic and Laboratory Test Reference 10th Edition: Mosby, Inc., Saint Louis, MO. Pp 928-930.
Tietz Textbook of Clinical Chemistry and Molecular Diagnostics. Burtis CA, Ashwood ER, Bruns DE, eds. St. Louis: Elsevier Saunders; 2006, 2011-2012.
Maggio M, et al. Sex hormone binding globulin levels across the adult lifespan in women - The role of body mass index and fasting insulin. J Endocrinol Invest. 2008 July; 31(7): 597–601. Available online at http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2648802/. Accessed February 2012.
Kelly JA, Vankrieeken L. Sex hormone binding globulin and the assessment of androgen status. Available online through http://www.medical.siemens.com. Accessed February 2012.
Reviewer May 2015: Nicole V. Tolan, PhD, DABCC, Associate Director of Chemistry and POCT, BIDMC and Harvard Medical School.
Isbell TS, Jungheim E, Gronowski AM. Reproductive endocrinology and related disorders. In: Burtis CA, Ashwood ER, Burns DE, eds. Tietz textbook of clinical chemistry and molecular diagnostics, Vol. 5th ed: Elsevier, 2012.
Pugeat M, Crave JC, Tourniaire J, Forest MG. Clinical utility of sex hormone-binding globulin measurement. Horm Res 1996;45:148-55.
Wheeler MJ. The determination of bio-available testosterone. Ann Clin Biochem 1995;32:345-57.
Ly LP, Sartorius G, Hull L, Leung A, Swerdloff RS, Wang C, Handelsman DJ. Original article: Accuracy of calculated free testosterone formulae in men. Clinical Endocrinology 2010;73:382-